StemCellPatents.com (www.stemcellpatents.com), an organization dedicated to dissemination of stem cell patent information, congratulates the Institute of Cellular Medicine (www.cellmedicine.com) for publishing the first peer reviewed paper describing a novel approach for utilizing stem cell therapy for the treatment of autism.
"The published proposal to leverage mesenchymal stem cells to ameliorate the intestinal inflammatory state found in the majority of autistic children, combined with administration of ex vivo expanded CD34 cells for overcoming hypoperfusion in various areas of the brain is of great interest to the stem cell community," said Dr. Zhaohui Zhong, Chairman of StemCellPatents.com.
The paper entitled "Stem Cell Therapy for Autism" was published in the June issue of the Journal of Translational Medicine and is freely available at: www.translational-medicine.com/content/pdf/1479-5876-5-30.pdf.
"We at StemCellPatents.com believe that sharing of information is critical for advancement of the field as a whole. While numerous clinics obtain many types of results with stem cell therapy, none to our knowledge make it a priority to educate the medical and public community with hard science. The fact that Cellmedicine is publishing peer reviewed papers and posting Youtube videos sets them aside from all other Ex-US stem cell clinics," concluded Dr. Zhong.
About StemCellPatents.com
StemCellPatents.com is an informal organization of concerned scientists, lawyers and intellectuals that assembled the only comprehensive index of all issued US stem cell patents: accessible freely as a Beta Version at www.stemcellpatents.com.